Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! online

Cancer

Volumn 117, Issue 18, 2011, Pages 4155-4165

  Gill, Sharlene ^a   Loprinzi, Charles ^b   Kennecke, Hagen ^a   Grothey, Axel ^b   Nelson, Garth ^b   Woods, Ryan ^a   Speers, Caroline ^a   Alberts, Steven R ^b   Bardia, Aditya ^c   O'Connell, Michael J ^d   Sargent, Daniel J ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b MAYO CLINIC   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NSABP Foundation Inc   (United States)

Author keywords

Adjuvant!; colon cancer; fluorouracil; nomogram; Numeracy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ACCURACY; ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; GENDER; HUMAN; INTERNET; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MODEL; NUMERACY AND ADJUVANT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SURVIVAL TIME; TUMOR CLASSIFICATION; VALIDATION STUDY;

AGED; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INTERNET; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROGNOSIS;

EID: 80052472118     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26003     Document Type: Article

References (13)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-249.
2. Committee CCSS. Canadian Cancer Statistics 2009. Toronto, Ontario: Canadian Cancer Society; 2009.
3. Gill S, Loprinzi CL, Sargent DJ, et al. ed analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004; 22: 1797-1806. (Pubitemid 41095169)
4. Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009; 27: 3109-3116.
5. Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol. 2007; 25: 2198-2204. (Pubitemid 46954643)
6. O'Connell MJ, Laurie JA, Kahn M, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol. 1998; 16: 295-300. (Pubitemid 28041612)
7. O'Connell MJ, Sargent DJ, Windschitl HE, et al. Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer. Clin Colorectal Cancer. 2006; 6: 133-139. (Pubitemid 44445748)
8. Bardia A, Loprinzi C, Grothey A, et al. Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of 2 widely used prognostic calculators. Semin Oncol. 2010; 37: 39-46.
9. Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol. 2005; 23: 2716-2725. (Pubitemid 46179461)
10. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006; 24: 5313-5327. (Pubitemid 46631379)
11. Kerr D, Gray R, Quirke P, et al. A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: selection of the genes in 4 large studies and results of the independent, prospectively designed QUASAR validation study [abstract]. J Clin Oncol. 2009; 27 (15s). Abstract 4000.
12. Hochster HS,. Web alert: adjuvant therapy for colon cancer. Curr Colorectal Cancer Rep. 2007; 4: 167-168.
13. Loprinzi CL, Ravdin PM, de Laurentiis M, Novotny P,. Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol. 1994; 12: 1422-1426. (Pubitemid 24206241)